Catalyst Wire Dossier Catalyst Wire Dossier

Azer-cel

· TG Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Azer-cel, covering 2026-02-02 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders [Phase 1]

See pricing